DBV Technologies S.A.

DBVT·NasdaqCM·Healthcare

Compare

9.55−0.25 (−2.55%)today

At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

After hours9.550.00 (0.00%)Oct 12, 4:00 PM EDT

Key statistics

Previous close9.80

Open9.63

Day range9.409.72

52-week range9.3626.19

Off day high−1.75%

Off 52-week high−63.53%

Volume311.79K

Avg. volume (3M)341.95K

Market cap600.20M

EPS (TTM)-3.50

Forward P/E-19.64

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)-0.24

Shares outstanding62.85M

Short interest1.79% of float

Earnings dateOct 28, 2026

Analyst target38.50

Profit margin0.00%

Against its peers

Compare in full ›

	DBVT	ATTO	ACRS	ABCL	LKFT	CABA
Market cap	600.20M	666.05M	529.92M	4.09B	1.94B	303.49M
P/E (TTM)	—	—	—	—	2.8	—
Forward P/E	-19.6	-6.1	-4.6	-16.6	-24.9	-1.5
Price/book	3.5	-0.5	4.0	4.3	10.5	1.4
Dividend yield	—	—	—	—	—	—
1-year change	−40.33%	−33.38%	+88.48%	+122.84%	−12.35%	−22.49%
Today	−2.55%	−9.99%	−6.01%	+0.72%	−0.54%	−7.25%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to DBV Technologies's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Attovia Therapeutics, Inc.ATTO · Biotechnology	666.05M	14.59	−9.99%
Aclaris Therapeutics, Inc.ACRS · Biotechnology	529.92M	3.6000	−6.01%
AbCellera Biologics Inc.ABCL · Biotechnology	4.09B	12.64	+0.72%
Lakefront Biotherapeutics NVLKFT · Biotechnology	1.94B	29.57	−0.54%
Cabaletta Bio, Inc.CABA · Biotechnology	303.49M	1.7900	−7.25%
Q32 Bio Inc.QTTB · Biotechnology	260.19M	8.74	+4.80%
Enanta Pharmaceuticals, Inc.ENTA · Biotechnology	358.24M	12.30	−1.60%
Protagonist Therapeutics, Inc.PTGX · Biotechnology	9.37B	144.88	+0.80%

Other companies in Biotechnology, closest in size first.

Company	Mkt cap	Price	Today
Silence Therapeutics plcSLN · London, United Kingdom	599.79M	9.65	−2.13%
Shattuck Labs, Inc.STTK · Austin, TX	611.21M	6.09	+2.01%
Phathom Pharmaceuticals, Inc.PHAT · Florham Park, NJ	576.82M	7.13	−1.66%
Climb Bio, Inc.CLYM · Wellesley Hills, MA	622.03M	10.83	−1.55%
CorMedix Inc.CRMD · Parsippany, NJ	581.46M	7.46	+1.08%
Sagimet Biosciences Inc.SGMT · San Mateo, CA	624.00M	8.80	−1.46%
Arbutus Biopharma CorporationABUS · Warminster, PA	636.10M	4.1500	−1.66%
Faeth Therapeutics, Inc.FTH · Rockville, MD	600.79M	23.25	−10.68%

Healthcare companies of a similar market value (602.09M).

Company	Mkt cap	Price	Today
Fulgent Genetics, Inc.FLGT · Diagnostics & Research	590.75M	21.47	−1.24%
Aquestive Therapeutics, Inc.AQST · Drug Manufacturers - Specialty & Generic	603.71M	4.8100	+0.63%
Weave Communications, Inc.WEAV · Health Information Services	593.72M	7.38	0.00%
Silence Therapeutics plcSLN · Biotechnology	599.79M	9.65	−2.13%
Shattuck Labs, Inc.STTK · Biotechnology	611.21M	6.09	+2.01%
Phathom Pharmaceuticals, Inc.PHAT · Biotechnology	576.82M	7.13	−1.66%
Ironwood Pharmaceuticals, Inc.IRWD · Drug Manufacturers - Specialty & Generic	621.30M	3.7600	−1.57%
SOPHiA GENETICS SASOPH · Health Information Services	614.62M	7.22	−2.56%

Also based in Châtillon, France, then elsewhere in France.

Company	Mkt cap	Price	Today
TotalEnergies SETTE · Courbevoie, France	195.07B	88.37	+2.62%
SanofiSNY · Paris, France	95.22B	39.74	−0.82%
ABIVAX Société AnonymeABVX · Paris, France	7.59B	86.94	−1.37%
Constellium SECSTM · Paris, France	3.46B	25.50	−1.20%
Pasqal Holding SAPSQL · Palaiseau, France	1.36B	6.40	−6.57%
Nanobiotix S.A.NBTX · Paris, France	1.19B	23.40	−1.18%
Criteo S.A.CRTO · Paris, France	752.11M	15.35	−2.42%
Inventiva S.A.IVA · Daix, France	737.01M	3.1200	−1.27%

Companies that serve the same markets: life sciences.

Company	Mkt cap	Price	Today
Nanobiotix S.A.NBTX · life sciences	1.19B	23.40	−1.18%
Replimune Group, Inc.REPL · life sciences	1.23B	13.07	−2.61%
Lakefront Biotherapeutics NVLKFT · life sciences	1.94B	29.57	−0.54%
Novavax, Inc.NVAX · life sciences	2.09B	12.66	−0.71%
Recursion Pharmaceuticals, Inc.RXRX · life sciences	2.15B	4.0100	−8.03%
Legend Biotech CorporationLEGN · life sciences	3.46B	17.80	−4.40%
Roivant Sciences Ltd.ROIV · life sciences	24.99B	34.59	−2.40%
First Tracks Biotherapeutics, Inc.TRAX · life sciences	1.22B	34.05	+6.91%

What visitors to DBV Technologies's page also look at.

Company	Mkt cap	Price	Today
CytomX Therapeutics, Inc.CTMX	527.32M	2.4200	−5.84%
InflaRx N.V.IFRX	234.32M	1.5900	−0.62%
Aclaris Therapeutics, Inc.ACRS	529.92M	3.6000	−6.01%
Assembly Biosciences, Inc.ASMB	463.61M	22.77	−3.23%
Solid Biosciences Inc.SLDB	719.48M	6.71	−2.33%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All DBVT news ›

Defense World·4d agoNegative

DBV Technologies (NASDAQ:DBVT) Sets New 1-Year Low – Time to Sell?

Shares of DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report) hit a new 52-week low on Thursday. The company traded as low as $9.64 and last traded at $9.77, with a volume of 535276 shares changing hands. The stock had previously closed…

@kalkineus·Sep 30

DBV Technologies Submits FDA Biologics License Application for VIASKIN Peanut Patch in Children Ages 4-7

kalkinemedia.com On September 29, 2026, DBV Technologies S.A. filed a Form 8-K with the SEC revealing the submission of a Biologics License Application (BLA) to the U.S. FDA for its VIASKIN Peanut Patch intended for children aged 4 to 7…

TradingView·Sep 30

DBV Technologies Submitted BLA To U.S. FDA For Viaskin Peanut Patch In Children Aged 4-7 Years

TradingView DBV Technologies Submitted BLA To U.S. FDA For Viaskin Peanut Patch In Children Aged 4-7 Years

From articles in the 4Search news index.

In the news

5mentions in 30 days

5with it in the headline

Negativesentiment

Most coverage from

defenseworld.net1
kalkinemedia.com1
marketscreener.com1
timothysykes.com1
tradingview.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

About

Profile ›

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research pro…

SectorHealthcare

IndustryBiotechnology

Chief executiveDaniel Tassé

Employees170

HeadquartersChâtillon, France

Websitedbv-technologies.com

Analyst ratings

Analysis ›

Buy7 analysts

Strong buy 1
Buy 5
Hold 0
Sell 1
Strong sell 0

12-month price target38.50+303.11%

Low 5.68Current 9.55High 54.23

Wall Street analyst consensus. Not a recommendation.

Earnings

Reported EPS
Estimate

Next report: Wed, Oct 28, 2026

Quarterly results

Financials ›

Revenue
Net income
Net margin −7,200.0% (Q2 '26)

Financial statements from company filings with the U.S. SEC (EDGAR XBRL).

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Most widely held	0	0	—
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.